Xerava 71773-0050
Generic: Eravacycline
Product NDC
71773-0050- Manufacturer
- Tetraphase Pharmaceuticals, Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 10, 2018
- Listing Expires
- December 31, 2026
- Application
- NDA211109
Need to source Xerava? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Eravacycline Dihydrochloride | 50 mg/1 |
Drug Class
Tetracycline-class Antibacterial [EPC]Tetracyclines [CS]
Packaging Options(2)
1 VIAL, GLASS in 1 CARTON (71773-050-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS
12 VIAL, GLASS in 1 CARTON (71773-050-12) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS